Barclays Maintains an 'Equalweight' on Hughes Communications (HUGH); 1Q11: Gross Adds Accelerate
HUGH Hot Sheet
Rating Summary:0 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 82
Barclays maintains an 'Equalweight' on Hughes Communications (NASDAQ: HUGH), PT $61.
Barclays analyst says, "HUGH reported strong subscriber adds in 1Q11, driven by improved marketing focus and government subsidies. Revenue was below
forecast, primarily due to timing issues related to telecom systems contracts and lower hardware sales in North America (as customers continued to prefer equipment leasing (which generates lower upfront hardware revenues) over outright purchases. Lower EBITDA was driven by one-time transaction expense related to company's acquisition by EchoStar. We believe the pending EchoStar (Nasdaq: SATS) transaction and Jupiter launch remain on track."
For more ratings news on Hughes Communications click here and for the rating history of Hughes Communications click here.
Shares of Hughes Communications closed at $59.79 yesterday, with a 52 week range of $21.19-$64.00.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Barclays analyst says, "HUGH reported strong subscriber adds in 1Q11, driven by improved marketing focus and government subsidies. Revenue was below
forecast, primarily due to timing issues related to telecom systems contracts and lower hardware sales in North America (as customers continued to prefer equipment leasing (which generates lower upfront hardware revenues) over outright purchases. Lower EBITDA was driven by one-time transaction expense related to company's acquisition by EchoStar. We believe the pending EchoStar (Nasdaq: SATS) transaction and Jupiter launch remain on track."
For more ratings news on Hughes Communications click here and for the rating history of Hughes Communications click here.
Shares of Hughes Communications closed at $59.79 yesterday, with a 52 week range of $21.19-$64.00.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Barclays Maintains an 'Equalweight' on Apollo Commercial Real Estate Finance (ARI); Effectively Using Capital, But Shares Trading In-line Vs. Peers
- Canaccord Genuity maintains a 'Buy' on Auxilium Pharmaceuticals (AUXL); Bumping Guidance on Testim Partnership with GSK
- Barclays Maintains an 'Equalweight' on Enbridge Energy Partners (EEP); Positive Long-Term on New Pipeline Projects
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
